[HbA1c of 6.5%. A rigid goal in diabetes therapy? (interview by Dr. Dirk Einecke)].
Hauner
Hans
H
D002544:Cerebral Infarction / Q000097:blood / Q000401:mortality / Q000517:prevention & control; D003131:Combined Modality Therapy; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy*; D003928:Diabetic Nephropathies / Q000097:blood / Q000401:mortality / Q000517:prevention & control; D003927:Diet, Diabetic; D004359:Drug Therapy, Combination; D006442:Glycated Hemoglobin / Q000378:metabolism*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000097:blood / Q000401:mortality / Q000517:prevention & control; D016032:Randomized Controlled Trials as Topic; D016019:Survival Analysis; D015996:Survival Rate
D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents